Comparative analyses of a cystic fibrosis isolate of bordetella bronchiseptica reveal differences in important pathogenic phenotypes

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1627-1637

  Sukumar, Neelima ^a   Nicholson, Tracy L ^b   Conover, Matt S ^a   Ganguly, Tridib ^a   Deora, Rajendar ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

O ANTIGEN; TRANSCRIPTOME; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; BORDETELLA BRONCHISEPTICA; CELL AGGREGATION; CELL MOTILITY; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; GENE EXPRESSION; GENE SEQUENCE; GENOME; HUMAN; IN VITRO STUDY; LABORATORY; MOUSE; NONHUMAN; OPERON; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RABBIT; RESPIRATORY SYSTEM; SEROTYPE;

ANIMALS; BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOFILMS; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; COMPARATIVE GENOMIC HYBRIDIZATION; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; FEMALE; GENOME, BACTERIAL; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; NOSE; PHENOTYPE; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 84896478586     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01453-13     Document Type: Article

References (65)

1. Heininger U, Stehr K, Schmitt-Grohe S, Lorenz C, Rost R, Christenson PD, Uberall M, Cherry JD. 1994. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13:306-309. http://dx.doi.org/10.1097/00006454-199404000-00011.
2. Goodnow RA. 1980. Biology of Bordetella bronchiseptica. Microbiol. Rev. 44:722-738.
3. Preston A, Parkhill J, Maskell DJ. 2004. The bordetellae: lessons from genomics. Nat. Rev. Microbiol. 2:379-390. http://dx.doi.org/10.1038/nrmicro886.
4. Musser JM, Bemis DA, Ishikawa H, Selander RK. 1987. Clonal diversity and host distribution in Bordetella bronchiseptica. J. Bacteriol. 169:2793-2803.
5. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382. http://dx.doi.org/10.1128/CMR.18.2.326-382.2005.
6. Harvill ET, Cotter PA, Miller JF. 1999. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect. Immun. 67:6109-6118.
7. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, Holden MT, Churcher CM, Bentley SD, Mungall KL, Cerdeno-Tarraga AM, Temple L, James K, Harris B, Quail MA, Achtman M, Atkin R, Baker S, Basham D, Bason N, Cherevach I, Chillingworth T, Collins M, Cronin A, Davis P, Doggett J, Feltwell T, Goble A, Hamlin N, Hauser H, Holroyd S, Jagels K, Leather S, Moule S, Norberczak H, O'Neil S, Ormond D, Price C, Rabbinowitsch E, Rutter S, Sanders M, Saunders D, Seeger K, Sharp S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Unwin L, Whitehead S, Barrell BG, Maskell DJ. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35:32-40. http://dx.doi.org/10.1038/ng1227.
8. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. 2005. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog. 1:e45. http://dx.doi.org/10.1371/journal.ppat.0010045.
9. Weyrich LS, Rolin OY, Muse SJ, Park J, Spidale N, Kennett MJ, Hester SE, Chen C, Dudley EG, Harvill ET. 2012. A type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One 7:e45892. http://dx.doi.org/10.1371/journal.pone.0045892.
10. Sloan GP, Love CF, Sukumar N, Mishra M, Deora R. 2007. The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract. J. Bacteriol. 189:8270-8276. http://dx.doi.org/10.1128/JB.00785-07.
11. Parise G, Mishra M, Itoh Y, Romeo T, Deora R. 2007. Role of a putative polysaccharide locus in Bordetella biofilm development. J. Bacteriol. 189: 750-760. http://dx.doi.org/10.1128/JB.00953-06.
12. Cummings CA, Bootsma HJ, Relman DA, Miller JF. 2006. Species-and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J. Bacteriol. 188:1775-1785. http://dx.doi.org/10.1128/JB.188.5.1775-178 5.2006.
13. Musser JM, Hewlett EL, Peppler MS, Selander RK. 1986. Genetic diversity and relationships in populations of Bordetella spp. J. Bacteriol. 166: 230-237.
14. Gueirard P, Weber C, Le Coustumier A, Guiso N. 1995. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J. Clin. Microbiol. 33:2002-2006.
15. Buboltz AM, Nicholson TL, Parette MR, Hester SE, Parkhill J, Harvill ET. 2008. Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J. Bacteriol. 190:5502-5511. http://dx.doi.org/10.1128/JB.00226-08.
16. Buboltz AM, Nicholson TL, Weyrich LS, Harvill ET. 2009. Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect. Immun. 77:3969-3977. http://dx.doi.org/10.1128/IAI.01362-08.
17. Park J, Zhang Y, Buboltz AM, Zhang X, Schuster SC, Ahuja U, Liu M, Miller JF, Sebaihia M, Bentley SD, Parkhill J, Harvill ET. 2012. Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics 13:545. http://dx.doi.org/10.1186/1471-2164-13-545.
18. Taylor LH, Latham SM, Woolhouse ME. 2001. Risk factors for human disease emergence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:983-989. http://dx.doi.org/10.1098/rstb.2001.0888.
19. Daszak P, Cunningham AA, Hyatt AD. 2000. Emerging infectious diseases of wildlife-threats to biodiversity and human health. Science 287: 443-449. http://dx.doi.org/10.1126/science.287.5452.443.
20. Woolfrey BF, Moody JA. 1991. Human infections associated with Bordetella bronchiseptica. Clin. Microbiol. Rev. 4:243-255.
21. Wernli D, Emonet S, Schrenzel J, Harbarth S. 2011. Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clin. Microbiol. Infect. 17:201-203. http://dx.doi.org/10.1111/j.1469-0691.2010.03258.x.
22. Stefanelli P, Mastrantonio P, Hausman SZ, Giuliano M, Burns DL. 1997. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J. Clin. Microbiol. 35:1550-1555.
23. Hadley K, Torres AM, Moran J, Schiller B. 2009. Bordetella bronchiseptica peritonitis-beware of the dog! Perit. Dial. Int. 29:670-671.
24. Dlamini NR, Bhamjee A, Levick P, Uniacke E, Ismail H, Smith A. 2012. Spontaneous bacterial peritonitis and pneumonia caused by Bordetella bronchiseptica. J. Infect. Dev. Ctries. 6:588-591.
25. Spilker T, Liwienski AA, LiPuma JJ. 2008. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin. Microbiol. Infect. 14:504-506. http://dx.doi.org/10.1111/j.1469-0691.200 8.01968.x.
26. Moissenet D, Bingen E, Arlet G, Vu-Thien H. 2005. Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis. Pathol. Biol. 53:500-502. http://dx.doi.org/10.1016/j.patbio.2005.06.004.
27. Ner Z, Ross LA, Horn MV, Keens TG, MacLaughlin EF, Starnes VA, Woo MS. 2003. Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr. Transplant. 7:413-417. http://dx.doi.org/10.1034/j.1399-3046.2003.00074.x.
28. Wallet F, Perez T, Armand S, Wallaert B, Courcol RJ. 2002. Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation. J. Clin. Microbiol. 40:2300-2301. http://dx.doi.org/10.1128/JCM.40.6.2300-2301.2002.
29. Register KB, Sukumar N, Palavecino EL, Rubin BK, Deora R. 2012. Bordetella bronchiseptica in a paediatric cystic fibrosis patient: possible transmission from a household cat. Zoonoses Public Health 59:246-250. http://dx.doi.org/10.1111/j.1863-2378.2011.01446.x.
30. Lipuma JJ. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23:299-323. http://dx.doi.org/10.1128/CMR.00068-09.
31. Brady C, Ackerman P, Johnson M, McNamara J. 2013. Bordetella bronchiseptica in a pediatric cystic fibrosis center. J. Cyst. Fibros. 13:43-48. http://dx.doi.org/10.1016/j.jcf.2013.08.002.
32. Cotter PA, Miller JF. 1994. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 62:3381-3390.
33. Nicholson TL, Buboltz AM, Harvill ET, Brockmeier SL. 2009. Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect. Immun. 77:4221-4231. http://dx.doi.org/10.1128/IAI.00136-09.
34. Stainer DW, Scholte MJ. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220. http://dx.doi.org/10.1099/00221287-63-2-211.
35. Nicholson TL. 2007. Construction and validation of a first-generation Bordetella bronchiseptica long-oligonucleotide microarray by transcriptional profiling of the Bvg regulon. BMC Genomics 8:220. http://dx.doi.org/10.1186/1471-2164-8-220.
36. Nicholson TL, Conover MS, Deora R. 2012. Transcriptome profiling reveals stage-specific production and requirement of flagella during biofilm development in Bordetella bronchiseptica. PLoS One 7:e49166. http://dx.doi.org/10.1371/journal.pone.0049166.
37. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121. http://dx.doi.org/10.1073/pnas.091062498.
38. Sukumar N, Mishra M, Sloan GP, Ogi T, Deora R. 2007. Differential Bvg phase-dependent regulation and combinatorial role in pathogenesis of two Bordetella paralogs, BipA and BcfA. J. Bacteriol. 189:3695-3704. http://dx.doi.org/10.1128/JB.00009-07.
39. Mishra M, Parise G, Jackson KD, Wozniak DJ, Deora R. 2005. The BvgAS signal transduction system regulates biofilm development in Bordetella. J. Bacteriol. 187:1474-1484. http://dx.doi.org/10.1128/JB.187.4.1474-1484.2005.
40. Buboltz AM, Nicholson TL, Karanikas AT, Preston A, Harvill ET. 2009. Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect. Immun. 77:3249-3257. http://dx.doi.org/10.1128/IAI.01448-08.
41. Stockbauer KE, Fuchslocher B, Miller JF, Cotter PA. 2001. Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein. Mol. Microbiol. 39:65-78. http://dx.doi.org/10.1046/j.1365-2958.2001.02191.x.
42. Deora R, Bootsma HJ, Miller JF, Cotter PA. 2001. Diversity in the Bordetella virulence regulon: transcriptional control of a Bvgintermediate phase gene. Mol. Microbiol. 40:669-683. http://dx.doi.org/10.1046/j.1365-2958.2001.02415.x.
43. Deora R. 2002. Differential regulation of the Bordetella bipA gene: distinct roles for different BvgA binding sites. J. Bacteriol. 184:6942-6951. http://dx.doi.org/10.1128/JB.184.24.6942-6951.2002.
44. Savelkoul PH, de Kerf DP, Willems RJ, Mooi FR, van der Zeijst BA, Gaastra W. 1996. Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion. Infect. Immun. 64:5098-5105.
45. Merkel TJ, Stibitz S. 1995. Identification of a locus required for the regulation of bvg-repressed genes in Bordetella pertussis. J. Bacteriol. 177: 2727-2736.
46. Cotter PA, Yuk MH, Mattoo S, Akerley BJ, Boschwitz J, Relman DA, Miller JF. 1998. Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect. Immun. 66:5921-5929.
47. Mattoo S, Miller JF, Cotter PA. 2000. Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect. Immun. 68:2024-2033. http://dx.doi.org/10.1128/IAI.68.4.2024-2033.2000.
48. Akerley BJ, Cotter PA, Miller JF. 1995. Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell 80: 611-620. http://dx.doi.org/10.1016/0092-8674(95)90515-4.
49. Akerley BJ, Monack DM, Falkow S, Miller JF. 1992. The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J. Bacteriol. 174:980-990.
50. Serra DO, Conover MS, Arnal L, Sloan GP, Rodriguez ME, Yantorno OM, Deora R. 2011. FHA-mediated cell-substrate and cell-cell adhesions are critical for Bordetella pertussis biofilm formation on abiotic surfaces and in the mouse nose and the trachea. PLoS One 6:e28811. http://dx.doi.org/10.1371/journal.pone.0028811.
51. Irie Y, Mattoo S, Yuk MH. 2004. The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica. J. Bacteriol. 186: 5692-5698. http://dx.doi.org/10.1128/JB.186.17.5692-5698.2004.
52. De Windt W, Gao H, Kromer W, Van Damme P, Dick J, Mast J, Boon N, Zhou J, Verstraete W. 2006. AggA is required for aggregation and increased biofilm formation of a hyper-aggregating mutant of Shewanella oneidensis MR-1. Microbiology 152:721-729. http://dx.doi.org/10.1099/mic.0.28204-0.
53. Wolfe DN, Goebel EM, Bjornstad ON, Restif O, Harvill ET. 2007. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussisinduced immunity. Infect. Immun. 75:4972-4979. http://dx.doi.org/10.1128/IAI.00763-07.
54. Wolfe ND, Dunavan CP, Diamond J. 2007. Origins of major human infectious diseases. Nature 447:279-283. http://dx.doi.org/10.1038/natur e05775.
55. Murphy TF, Bakaletz LO, Smeesters PR. 2009. Microbial interactions in the respiratory tract. Pediatr. Infect. Dis. J. 28:S121-126. http://dx.doi.org/10.1097/INF.0b013e3181b6d7ec.
56. Morris DP. 2007. Bacterial biofilm in upper respiratory tract infections. Curr. Infect. Dis. Rep. 9:186-192. http://dx.doi.org/10.1007/s11908-007-0030-3.
57. Vlastarakos PV, Nikolopoulos TP, Maragoudakis P, Tzagaroulakis A, Ferekidis E. 2007. Biofilms in ear, nose, and throat infections: how important are they? Laryngoscope 117:668-673. http://dx.doi.org/10.1097/MLG.0b013e318030e422.
58. Kobayashi H. 2005. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Treatments Resp. Med. 4:241-253. http://dx.doi.org/10.2165/00151829-200504040-00003.
59. Sisti F, Ha DG, O'Toole GA, Hozbor D, Fernandez J. 2013. Cyclic-di-GMP signalling regulates motility and biofilm formation in Bordetella bronchiseptica. Microbiology 159:869-879. http://dx.doi.org/10.1099/mic.0.064345-0.
60. Sugisaki K, Hanawa T, Yonezawa H, Osaki T, Fukutomi T, Kawakami H, Yamamoto T, Kamiya S. 2013. Role of (p)ppGpp in biofilm formation and expression of filamentous structures in Bordetella pertussis. Microbiology 159:1379-1389. http://dx.doi.org/10.1099/mic.0.066597-0.
61. Costerton JW. 2001. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol. 9:50-52. http://dx.doi.org/10.1016/S0966-842X(00)01918-1.
62. Jakobsen TH, Hansen MA, Jensen PO, Hansen L, Riber L, Cockburn A, Kolpen M, Ronne Hansen C, Ridderberg W, Eickhardt S, Hansen M, Kerpedjiev P, Alhede M, Qvortrup K, Burmolle M, Moser C, Kuhl M, Ciofu O, Givskov M, Sorensen SJ, Hoiby N, Bjarnsholt T. 2013. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLoS One 8:e68484. http://dx.doi.org/10.1371/journal.pone.0068484.
63. Mikkelsen H, McMullan R, Filloux A. 2011. The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS. PLoS One 6:e29113. http://dx.doi.org/10.1371/journal.pone.0029113.
64. Mann EE, Wozniak DJ. 2012. Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol. Rev. 36:893-916. http://dx.doi.org/10.1111/j.1574-6976.2011.00322.x.
65. Ahuja U, Liu M, Tomida S, Park J, Souda P, Whitelegge J, Li H, Harvill ET, Parkhill J, Miller JF. 2012. Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol. 12:167. http://dx.doi.org/10.1186/1471-2180-12-167.